Global Fibrinolytic Therapy Market: Nā ʻano o kēia manawa, ka nānā ʻana a me nā manaʻo e hiki mai ana

ʻO ka mākeke fibrinolytic therapy e pili ana i ka lāʻau lapaʻau e pili ana i ka hoʻomohala ʻana, hana a me ka hāʻawi ʻana i nā lāʻau lapaʻau i hoʻohana ʻia i ka lāʻau fibrinolytic.

ʻO ka lāʻau Fibrinolytic e pili ana i ka hoʻohana ʻana i nā lāʻau lapaʻau e wāwahi i ke koko i hana ʻia i loko o nā kīʻaha koko, no laila e hoʻihoʻi hou i ke kahe o ke koko i ka wahi i hoʻopilikia ʻia.

ʻO ka pahuhopu nui o ka lāʻau fibrinolytic ka hoʻopau ʻana i nā clots koko a pale i nā pilikia e pili ana i nā kīʻaha koko i hoʻopaʻa ʻia. Hoʻohana pinepine ʻia kēia lāʻau lapaʻau i ka mālama ʻana i nā ʻano like ʻole, e like me ka maʻi ischemic stroke, pulmonary embolism, deep vein thrombosis, a me ka myocardial infarction (ka puʻuwai puʻuwai).

Hana nā lāʻau lapaʻau Fibrinolytic ma o ka hoʻoulu ʻana i ke kaʻina hana kūlohelohe o ke kino o ka fibrinolysis, e pili ana i ka wāwahi ʻana i ka fibrin, kahi protein e hoʻokumu i ka ʻupena o ke koko. Hoʻoulu kēia mau lāʻau lapaʻau i ka hoʻokuʻu ʻana o ka plasminogen, kahi precursor hana ʻole, a laila hoʻololi i ka plasmin, kahi enzyme kuleana no ka hoʻopau ʻana i nā clots fibrin.

ʻO kekahi mau lāʻau fibrinolytic i hoʻohana mau ʻia me ka alteplase, tenecteplase, a me ka reteplase. Hāʻawi ʻia kēia mau lāʻau lapaʻau e ka infusion intravenous a koi i ka nānā pono ʻana ma muli o nā hopena ʻaoʻao, e like me ka hoʻopiʻi koko.

ʻO ka mākeke

Ke alakaʻi ʻia nei ka mākeke fibrinolytic therapy e ka ulu ʻana o ka maʻi cardiovascular a me ka piʻi nui o ka noi no nā koho lapaʻau kūpono. ʻO nā mea e like me ka heluna kanaka ʻelemakule, ka nohona sedentary, a me nā ʻano meaʻai maikaʻi ʻole e kōkua i ka piʻi nui ʻana o nā kūlana pili i ke koko, a laila e hoʻoulu ai i ka noi no nā lāʻau fibrinolytic.

ʻO nā mea pāʻani nui i ka mākeke fibrinolytic therapy e pili ana i nā hui lāʻau lapaʻau, nā keʻena noiʻi, a me nā limahana mālama olakino. Hana pū kēia mau hui e hoʻomohala a kūʻai aku i nā lāʻau fibrinolytic hou, hana i nā hoʻokolohua lapaʻau, a aʻo i nā limahana mālama ola i ka hoʻohana pono ʻana i kēia mau lāʻau lapaʻau.

Ka holomua ʻenehana

ʻO ka holomua ʻenehana i nā ʻōnaehana hoʻopuka lāʻau a me ka noiʻi mau ʻana i nā mea hou fibrinolytic e manaʻo ʻia e alakaʻi i ka ulu mākeke. Eia kekahi, ʻo ka ulu nui ʻana o ka lāʻau lapaʻau pilikino a me nā lāʻau lapaʻau i hoʻopaʻa ʻia e hiki ke alakaʻi i ka hoʻomohala ʻana i nā lāʻau fibrinolytic ʻoi aku ka pololei a me ka maikaʻi i ka wā e hiki mai ana.

I ka hopena, he hana koʻikoʻi ka mākeke fibrinolytic therapy i ka hoʻoponopono ʻana i nā kūlana pili i ke koko e ka hāʻawi ʻana i nā lāʻau lapaʻau e hoʻopau i nā clots a hoʻihoʻi i ke kahe koko. Me ka piʻi nui o ka maʻi cardiovascular, e hoʻonui paha kēia mākeke i ka holomua o ka noiʻi a me ka ʻenehana e hoʻomaikaʻi i nā koho lapaʻau.

BlogInnovazione.it